1 Min Read
Oct 13 (Reuters) - Johnson & Johnson -
* Janssen announces U.S. FDA approval of Stelara® (ustekinumab) for the treatment of adolescents with moderate to severe plaque psoriasis Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.